In traditional medicine, Cannabis sativa has been prescribed for a variety of diseases.
Today, the plant is largely known for its recreational purpose, but it may find a way back to …

Background and Aims Despite reported adverse effects of opioids in patients with
inflammatory bowel disease (IBD), the burden of opioid use in this population appears to be …

Background and Aim Data on patient needs and access to psychological services in
inflammatory bowel disease (IBD) are scarce. This study aimed to describe the levels of …

Inflammatory bowel disease (IBD) is a chronic and potentially devastating condition of the
digestive tract which is exemplified by increasing prevalence worldwide, byzantine …

Background Pain is commonly experienced by patients with inflammatory bowel disease
(IBD). Unfortunately, pain management is a challenge in IBD care, as currently available …

Pragmatic clinical research is part of five focus areas of the Challenges in IBD research
document, which also includes preclinical human IBD mechanisms, environmental triggers …

The management of chronic noncancer pain (CNCP) with chronic opioid therapy (COT) is
controversial. There is a lack of consensus on how COT is defined resulting in unclear …

Bidirectional interactions of the gut epithelium with commensal bacteria are critical for
maintaining homeostasis within the gut. Chronic opioid exposure perturbs gut homeostasis …

Inflammatory bowel diseases (IBD) belong to a subgroup of persistent, long-term,
progressive, and relapsing inflammatory conditions. IBD may spontaneously develop in the …

Abstract Background 5-aminosalicylate (5-ASA) medications have a long history of use for
the treatment of inflammatory bowel disease and continue to be widely prescribed today …